PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC.

Racherla KS, Dovalovsky K, Patel M, Harper E, Barnard J, Nasifuzzaman SM, Smith M, Sikand R, Drinka E, Puri N

Open source

DOI
10.3390/cancers15133461
Published
2023 Jul 1
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers15133461,
  title = {PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC.},
  author = {Racherla KS and Dovalovsky K and Patel M and Harper E and Barnard J and Nasifuzzaman SM and Smith M and Sikand R and Drinka E and Puri N},
  year = {2023},
  journal = {Cancers},
  doi = {10.3390/cancers15133461},
  url = {https://doi.org/10.3390/cancers15133461}
}

RIS

TY  - JOUR
TI  - PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC.
AU  - Racherla KS
AU  - Dovalovsky K
AU  - Patel M
AU  - Harper E
AU  - Barnard J
AU  - Nasifuzzaman SM
AU  - Smith M
AU  - Sikand R
AU  - Drinka E
AU  - Puri N
PY  - 2023
JO  - Cancers
DO  - 10.3390/cancers15133461
UR  - https://doi.org/10.3390/cancers15133461
ER  - 

APA

KS, R., K, D., M, P., E, H., J, B., SM, N., M, S., R, S., E, D., & N, P. (2023). PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC.. Cancers. https://doi.org/10.3390/cancers15133461

Source records